Specifications TableSubjectClinical NeurologySpecific subject areaNeurosurgery and GerontologyType of dataTableHow data were acquiredWe investigated the medical records of our hospital. We collected objective data from them, such as patients\' comorbidities, prognosis, laboratory data, and physiological symptoms. We also investigated the computed tomography images to obtain information on the temporal muscle.Data formatRawParameters for data collectionFrom medical records, we collected objective data like laboratory data. Radiological information, such as temporal muscle profile, could be less objective, so we calculated their averages of the left and right from three determinations of each side by two investigators.Description of data collectionFrom the subarachnoid hemorrhage databases of our hospital, we retrospectively retrieved the data from all of the 24 patients with aneurysmal subarachnoid hemorrhage over 75. The patients\' World Federation of Neurosurgical Societies grade were I to III, and they underwent aneurysm intervention. We collected data regarding physiological symptoms and laboratory data on admission from medical records. Radiological information, including temporal muscle profile, was gained using computed tomography images. Outcomes and activities of daily living before hospitalization were assessed by the modified Rankin Scale. The outcome was evaluated about four weeks after admission in our acute care hospital.Data source locationSuwa Red Cross Hospital\
Suwa, Nagano, Japan, 36.0430059, 138.1068495Data accessibilityWith the articleRelated research articleMasahito Katsuki, Yasunaga Yamamoto, Toshiya Uchiyama, Naomichi Wada, Yukinari Kakizawa\
Clinical Characteristics of Aneurysmal Subarachnoid Hemorrhage in the Elderly Over 75; Would Temporal Muscle Be a Potential Prognostic Factor as an Indicator of Sarcopenia?\
Clinical Neurology and Neurosurgery 186 (2019) 105535\
<https://doi.org/10.1016/j.clineuro.2019.105535>**Value of the Data**•First data of the relationship between temporal muscle and outcome of the elderly patients with subarachnoid haemorrhage.•This data can be used as a reference series for clinical neurologist and neurosurgeon to investigate the characteristics of elderly patients with subarachnoid haemorrhage.•The data of temporal muscle thickness/area and modified Rankin Scale at discharge can be used to compare similar elderly patients in other hospital and to investigate novel prognostic factors.

Data {#sec1}
====

The dataset in this article describes the characteristics of elderly patients over 75 with subarachnoid hemorrhage whose World Federation of Neurosurgical Societies grade were I to III. We retrospectively collected data from medical records in our hospital regarding physiological symptoms, laboratory data, radiological data on admission, and outcomes at discharge. [Table 1](#tbl1){ref-type="table"} shows the each variables as candidates of prognostic factors.Table 1Characteristics of the elderly patients over 75 with SAH whose WFNS grade were I to III.Table 1PatientAgeSexPremorbid mRSFisher GroupWFNS GradeAlb (g/dL)WBC (/mm^3^)Lymph (/mm^3^)T-Cho (mg/dL)TMT (mm)TMA (mm^2^)Height (cm)Weight (kg)sBP (mmHg)TG (mg/dL)LDL (mg/dL)BS (mg/dL)HbA1c (%)HydrocephalusSymptomatic vasospasmSize (mm)Antithrombotic drugTreatmentLocationmRS at discharge176F0313162.71285.332213.94109.5142402252061061346----14.16--CoilingICA0276F0313.774.4446.45.44198.515944.3155----9.46+CoilingBA0386F2324139.58375005.78514015045.113859103239--+15.83--ClippingICA0486F0324.360.22690.942034.6173.5145431101151415.8----11.75+ClippingACoA0579F0324.168.53000.31776.53527314249.51941861071726----7.33--ClippingICA0678F032454.93189.692055.0927615448.318872107----6.6--ClippingICA0784F0324.575.3783.122033.345107.79514840.5147601211466.2----3.72--ClippingACoA1885F0324.4190.41999.21624.63107.815125.836.217694100141----2.44--ClippingICA1975F0323.975.41711.581475.3215.515048145132761505.1----6--ClippingVA21085F3223.595.41039.861963.94511314843.5152701271325.4----2.7--ClippingACoA31183F1324.8125.4514.142955.09521815549.6147792506.9+--8.1--ClippingICA41278F0323.773.31092.172.94156.514841.4188126+--6.62+ClippingMCA41381F0324.1751192.52064.68227.514631.41451091022085.7+--9.19--ClippingICA41481F432462.22892.32402.7545.516255.8188116165132----2.3--CoilingBA41588F0324.158.82357.881632.55015336.617743861275.4--+5.1--CoilingBA41693F4323.684.5481.651803.77117.515044.3132591091216.6----5.4--ClippingACoA41796F0423.554.6589.682.6351.3514031.91331495.6----8--ClippingACA51877F0214.356.11789.592225.595145.93515155.81351871321045.7----5.34--ClippingACoA51980M0313.8150.11065.711533.395111.5147.746144631705.2----6--ClippingACoA02088M0213.673.2461.165.155274.51654713142711416.1----2.67--ClippingMCA02176M0323.6115.4473.141877.505419.517659.81571041174175.8--+5.26--ClippingMCA02293M1213.9727921514.6255.514945.115353----5.8--ClippingMCA22385M0223.758.1772.73167519216248.5152117996.4----3.05--ClippingICA32483M0324.1135.72252.622774.74517816047.41714102887.8+--5--ClippingMCA5[^1]

2. Experimental design, materials, and methods {#sec2}
==============================================

From the subarachnoid hemorrhage (SAH) databases of our hospital, we retrospectively retrieved the data from all of the 49 patients with aneurysmal SAH over 75 who had been admitted from 2014 to 2018. Of the 49 patients, 24 patients were described in this report; The patients\' World Federation of Neurosurgical Societies grade \[[@bib2]\] were I to III, and they underwent aneurysm intervention. We collected data regarding physiological symptoms and laboratory data on admission.

We determined the size of the aneurysm, location of the aneurysm, the temporal muscle thickness (TMT), and temporal muscle area (TMA) based on the results of computed tomography (CT) and computed tomography angiography (CTA) on admission. We used Aquilion ONE (Canon Medical Systems Corporation, Tochigi, Japan) to take CT and CTA images of 0.5 × 0.5 × 1.0 mm voxels. The slice thickness was reconstructed to 5 mm. The window width was adjusted to 300, and the window level was adjusted to 20. The TMT and TMA were measured by two investigators who did not know the patients\' outcomes using SYNAPSE V 4.1.5 imaging software (Fujifilm Medical, Tokyo, Japan). The TMT was measured bilaterally perpendicular to the long axis of the temporal muscle at the slice 5 mm above the orbital roof, and calculated using averages of the left and right from three determinations of each side. The TMA was measured manually by tracing the outline of the temporal muscle on the same slice as used for measuring the TMT and computed by the software. We calculated their averages of the left and right from three determinations of each side by two investigators \[[@bib1]\].

Symptomatic vasospasm was diagnosed by CT, CTA, magnetic resonance imaging (MRI), or magnetic resonance angiography with symptoms. CT or MRI diagnosed hydrocephalus with symptoms. Outcomes and activities of daily living (ADL) before hospitalization were assessed by the modified Rankin Scale \[[@bib3]\] (mRS). We dichotomized ADL before hospitalization and at discharge into favorable (mRS 0--2) or poor (mRS 3--6) about four weeks after admission in our acute care hospital.
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